CONTRIBUTION OF SORBITOL COMBINED WITH ACTIVATED-CHARCOAL IN PREVENTION OF SALICYLATE ABSORPTION

被引:24
作者
KELLER, RE
SCHWAB, RA
KRENZELOK, EP
机构
[1] Department of Emergency Medicine, Susquehanna Poison Center, Geisinger Medical Center, Danville, PA
[2] Children's Hospital of Pittsburgh, Pittsburgh Poison Center, Pittsburgh, PA
关键词
activated charcoal; cathartic; salicylate; sorbitol;
D O I
10.1016/S0196-0644(05)82470-9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The use of cathartics and activated charcoal in treating toxic ingestions has become a standard treatment modality. Sorbitol has been shown to be the most rapidly acting cathartic, but its therapeutic significance has been debated. Using a previously described aspirin overdose model, ten healthy volunteers participated in a crossover design study that investigated the effect of activated charcoal alone versus that of activated charcoal and sorbitol in preventing salicylate absorption. In phase 1 of the study, subjects consumed 2.5 g aspirin followed by 25 g activated charcoal one hour later. Urine was collected for 48 hours and analyzed for quantitative salicylate metabolites. Phase 2 was identical except that 1.5 g/kg sorbitol was consumed with the activated charcoal. The mean amount of aspirin absorbed without the use of sorbitol was 1.26 ± 0.15 g, whereas the mean absorption was 0.912 ± 0.18 g with the addition of sorbitol. This is a 28% decrease in absorption of salicylates attributable to the use of sorbitol. The difference is significant at P < .05 by the paired Student's t test. This study demonstrates that the addition of sorbitol significantly decreases drug absorption in a simulated drug overdose model. Effects on absorption in actual overdose situations and on patient outcome should be the subjects of further study. © 1990 American College of Emergency Physicians.
引用
收藏
页码:654 / 656
页数:3
相关论文
共 19 条
[1]  
Ellenhorn, Barceloux, Medical Toxicology Diagnosis and Treatment of Human Poisoning, (1988)
[2]  
Flomenbaum, Goldfrank, Kulberg, Et al., General management of the poisoned or overdosed patient, Goldfrank's Toxicologic Emergencies, (1986)
[3]  
Curtis, Barone, Giacona, Efficacy of ipecac and activated charcoal/cathartic: Prevention of salicylate absorption in a simulated overdose, Arch Intern Med, 144, pp. 48-52, (1984)
[4]  
Krenzelok, Heller, Effectiveness of commercially available aqueous activated charcoal products, Ann Emerg Med, 16, pp. 1340-1343, (1987)
[5]  
Neuvonen, Clinical pharmacokinetics of oral activated charcoal in acute intoxications, Clin Pharmacokinet, 7, pp. 465-489, (1982)
[6]  
McNamara, Aaron, Gemborys, Et al., Sorbitol catharsis does not enhance efficacy of charcoal in simulated acetaminophen overdose, Ann Emerg Med, 17, pp. 243-246, (1988)
[7]  
Goldberg, Spector, Park, Et al., The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow release theophylline, Clin Pharmacol Ther, 41, pp. 108-111, (1987)
[8]  
Chin, Picchioni, Gillespie, Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments, Clin Toxicol, 18, pp. 865-871, (1981)
[9]  
Sketris, Mowry, Czajka, Et al., Saline catharsis: Effect on aspirin bioavailability in combination with activated charcoal, J Clin Pharmacol, 22, pp. 59-64, (1982)
[10]  
Easom, Caraccio, Lovejoy, Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans, Clin Pharmacol, 1, pp. 154-156, (1982)